Schedule Dispatches

July 2026

New Listings

• Budesonide with glycopyrronium and eformoterol (Breztri Aerosphere) aerosol inhaler budesonide 160 mcg with glycopyrronium 7.2 mcg and formoterol 5 mcg per dose, 120 dose OP – Special Authority – Retail pharmacy (p’code 2730936)
• Colchicine (Colchicine Indoco) tab 500 mcg (p’code 2731576)
• Glucose [dextrose] (HypoPak Glucose) oral soln 15 g per 80 ml sachet (p’code 2616394)
• Insulin syringes, disposable with attached needle (Embecta Ultra Fine) syringe 0.5 ml with 31 g × 8 mm needle (p’code 2731894) and syringe 1 ml with 31 g × 8 mm needle (p’code 2731886) – Maximum of 200 dev per three months
• Methotrexate (Methotrexate Pharmascience) inj 7.5 mg prefilled syringe – s29 (p’code 2733102)
• Moxifloxacin (Moximed) tab 400 mg – Special Authority – Retail pharmacy – no patient co-payment payable (p’code 2717913)
• Paediatric oral feed 1kcal/ml (Pediasure) liquid (chocolate), 200 ml bottle, 1 OP – Special Authority – Hospital pharmacy [HP3] (p’code 2731592)
• Paraffin liquid with wool fat (Poly-Visc) eye oint 3% with wool fat 3%, 3.5 g OP (p’code 2718626)
• Promethazine hydrochloride (XGen) inj 25 mg per ml, 1 ml ampoule – s29 and wastage claimable (p’code 2733374)
• Rosuvastatin (Rosuvastatin Mylan) tab 5 mg (p’code 2727870), tab 10 mg (p’code 2727889), tab 20 mg (p’code 2727897) and tab 40 mg (p’code 2727900) – Special Authority – Retail pharmacy
• Pharmacy services (BSF AutoSoft 90) brand switch fee – may only be claimed once per patient (p’code 2733498)
• Temozolomide (Temozolomide (Devatis)) cap 5 mg – Special Authority – Retail pharmacy – s29 and wastage claimable (p’code 2733188)
• Tenecteplase (Metalyse) inj 50 mg per vial with diluent – Subsidy by endorsement, up to 1 inj available on a PSO and only on a PSO (p’code 2028743)
• Teriflunomide (Teriflunomide Aurobindo) tab 14 mg – Special Authority – Retail pharmacy – s29, wastage claimable and treatment on two or more funded multiple sclerosis treatments simultaneously is not permitted (p’code 2733099)
• Testosterone undecanoate (Gonadron) inj 250 mg per ml, 4 ml vial (p’code 2721368)
• Thiamine hydrochloride (Thiamine-REX) tab 50 mg – Only on a prescription (p’code 2716372)
• Ursodeoxycholic acid (APO-Ursodeoxycholic Acid) cap 250 mg – Special Authority – Retail pharmacy – s29 and wastage claimable (p’code 2729504)
• Valaciclovir (Valaciclovir Viatris) tab 500 mg – s29 and wastage claimable (p’code 2725983)
• Vancomycin (Vancomycin Viatris) inj 500 mg vial, 10 inj – Subsidy by endorsement (p’code 2706113)                    

Changes to restrictions, chemical names and presentations

• Benzathine benzylpenicillin (Benzetacil) inj 900 mg (1.2 million units) vial – removal of S29 rule and addition of PSO
• Eye preparations – amended note
• Insulin pump infusion set (teflon cannula, straight insertion with insertion device) (AutoSoft 90) – addition of brand switch fee
  • 6 mm teflon cannula; straight insertion; insertion device; 110 cm line × 10 with 10 needles
  • 6 mm teflon cannula; straight insertion; insertion device; 60 cm line × 10 with 10 needles
  • 9 mm teflon cannula; straight insertion; insertion device; 110 cm line × 10 with 10 needles
  • 9 mm teflon cannula; straight insertion; insertion device; 60 cm line × 10 with 10 needles
• Perindopril (Coversyl) tab 2 mg, 4 mg and 8 mg – removal of stat dispensing
• Potassium chloride (LumaCina) inj 75 mg per ml, 10 ml – addition of s29 and wastage claimable
• Pregabalin (Lyrica and Pregabalin Pfizer) cap 25 mg, 75 mg, 150 mg and 300 mg – removal of brand switch fee
• Progesterone (Utrogestan) cap 100 mg – reinstate stat dispensing
• Sunitinib (Sunitinib Rex) cap 12.5 mg, 25 mg and 50 mg – amended Special Authority criteria
• Temozolomide – amended Special Authority criteria
  • Cap 5 mg (Temaccord, Temozolomide Taro and Temozolomide (Devatis))
  • Cap 20 mg (Temaccord and Apo-Temozolomide)
  • Cap 100 mg (Temaccord and Apo-Temozolomide)
  • Cap 140 mg (Temaccord)
  • Cap 250 mg (Temaccord)
• Tetracycline (Accord) tab 250 mg – removal of Special Authority and addition of subsidy by endorsement
• Ticagrelor (Ticagrelor Sandoz, Ticagrelor Sandoz S29 and Ticagrelor Mylan) tab 90 mg – addition of subsidy by endorsement waived by Special Authority

Increased subsidy

Chemical	Presentation	Fully subsidised brands
Bacillus Calmette-Guerin (BCG) vaccine	Inj 2-8 x 100 million CFU	OncoTICE
Cyclopentolate hydrochloride	Eye drops 1%, 15 ml OP	Cyclogyl
Hydrocortisone with cinchocaine	Oint 5 mg with cinchocaine hydrochloride 5 mg per g, 30 g OP	Proctosedyl
	Suppos 5 mg with cinchocaine hydrochloride 5 mg per g
Tropicamide	Eye drops 0.5% and 1%, 15 ml OP	Mydriacyl

Decreased subsidy

Chemical	Presentation	Fully subsidised brands
Ciprofloxacin	Tab 500 mg	Ipca-Ciprofloxacin
Darunavir	Tab 400 mg and 600 mg	Darunavir Viatris
Emulsifying ointment	Oint BP, 500 g	Evara Emulsifying Ointment
Ezetimibe	Tab 10 mg	Ezetimibe Sandoz
Febuxostat	Tab 80 mg and 120 mg	Febuxostat (Teva)
Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride	Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg	Movicol
Magnesium sulphate	Inj 2 mmol per ml, 5 ml ampoule	Martindale
Mebeverine hydrochloride	Tab 135 mg	Colofac
Melphalan	Inj 50 mg	Melpha
Paracetamol	Tab 500 mg - blister pack	Pacimol
Paraffin	White soft, 2,500 g	EVARA White Soft Paraffin
Quetiapine	Tab 25 mg, 100 mg, 200 mg and 300 mg	Quetapel
Rizatriptan	Tab orodispersible 10 mg	Rizamelt Rizatriptan Viatris
Simvastatin	Tab 10 mg, 20 mg, 40 mg and 80 mg	Simvastatin Viatris
Sodium citro-tartrate	Grans eff 4 g sachets	Ural
Sodium valproate	Inj 100 mg per ml, 4 ml	Epilim IV
Triamcinolone acetonide	Paste 0.1%, 5 g OP	Kenalog in Orabase
Vitamins	Tab (BPC cap strength)	Mvite